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syndrome. We also determined the association between BMI and
ferritin as well as the ferritin level that best predicted a hb level
below our populations reference interval (RI) lower limit.
Methods
We used participant data collected as part of a global study
conducted by the International Federation of Clinical Chemistry
(IFCC) to determine adult reference intervals (RIs) for common
laboratory tests. Kenya is one of the participating countries and
recruited adults aged 18–65 years using a harmonized inclusion and
exclusion criteria. Ferritin levels were determined using a Beckman
Coulter DXI analyzer, ultrasensitive CRP (usCRP) using a Beckman
Coulter AU5800, while CBC analysis was performed on a Beckman
Coulter ACT 5 DIFF CP analyzer (Brea, California, US). Mann-Whitney
U test was used to compare hb, ferritin and usCRP levels between
males and females. The correlations between hb and ferritin, usCRP
and ferritin were determined using Pearson's correlation. Compari-
son of ferritin across BMI categories of normal, overweight and obese
was done using Kruskal-Wallis H and post hoc assessment using
Tukey's test. Receiver operating curve (ROC) and Youden index was
used to determine the ferritin cut-off that best predicted IDA.
Results
We reviewed data from 528 participants who had laboratory
results for all analytes of interest. There were 254 males and 274
females with median ages (interquartile range (IQR)) of 38 (19) and
39 (20) years respectively. There was a statistically significant
difference in median hb (U = 4751, p= .000), ferritin (U = 11,128,
p = .000) and usCRP (U = 27,176, p = .000) between males and
females. The median (IQR) levels for males and females were 16.7
(1.3) and 14.2 (1.6) g/dl for hb, 122 (142) and 28.5 (51) μg/L for
ferritin, 0.96 (2) and 1.66 (3.14) mg/L for usCRP respectively. The
median (IQR) BMI for males and females was 24.89 (5.64) and 26.08
(6.23) kg/m2 respectively. There was a positive correlation between
hb and ferritin which was statistically significant (r= 0.370, n=
528, p = .000). The correlation between usCRP and ferritin was not
statistically significant (r = 0.039, n = 528, p= .373). The difference
in ferritin levels across BMI categories was statistically significant (|2
(2) = 6.893, p = .032) with ferritin levels for both overweight (p =
.011) and obese (p= .024) being higher than those with a normal
BMI. The difference in ferritin levels between overweight and obese
categories was not statistically significant (p = .917). A ferritin level
below 8.5 μg/L best predicted a reduced hb defined as b12 g/dL for
females and 14.5 g/dL in males with a sensitivity of 94% and
specificity of 71%. Using a hb of 11 g/dL to define IDA, a ferritin level
of 6.5 μg/L was the best predictor with a sensitivity and specificity of
95.7% and 93.8% respectively.
Conclusions
As expected, a decline in ferritin level was associated with a
reduction in hb with a ferritin level below 8.5 μg/L having the highest
sensitivity and specificity for diagnosing IDA as defined using the
lower RI limits that we have established for our population. Using the
WHO hb cut-off of 11 g/dL to define IDA, the optimal ferritin cut-off
would be 6.5 μg/L. These values are much lower than the 15 μg/L
recommended byWHOand the 30 μg/L recommendedwhen assessing
iron deficiency in a populationwith a high prevalence of inflammation.
This highlights the importance of population specific ferritin cut-offs
for assessment of iron deficiency to avoid misdiagnosis.
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Background-aim
Polycystic Ovary Syndrome (PCOS) affects 4–8% of pre-meno-
pausal women and it is the most common endocrine disorder during
childbearing age.Although many diagnostic criteria have been
established for PCOS within the past century and no consensus has
yet been reached, it has been found that PCOS in the long term does
not only affect reproductive health, but also insulin resistance and
inflammation are risk factors for cardiovascular diseases, metabolic
syndrome and diabetes.The aim of this study was to investigate the
cytokine levels and the progress of the proinflammation process.
Methods
The study was carried out on patients who were referred to
Istanbul University Cerrahpaşa Medical Faculty, Department of
Obstetrics and Gynecology, Infertility and IVF clinic with PCOS
complaint. The control group was formed from fertile and non-
chronic women. After taking the blood of the patients, the serum
part was separated by centrifugation and stored at −30 °C in
appropriate ependorfs. Analysis of MCP-1 and IL-18 levels in serum
samples from patients and control group was performed by ELISA.
Washing of ELISA plates was carried out on Biotek brand ELX-50
model and reading on Biotek ELX-800 model. We studied 33 patients
from 31 control groups. The mean age of the patients is 26 ± 4.5 and
the mean age of the controls is 25 ± 6 years. The Body Mass Index
(BMI) is 24 ± 4 kg / m2 in patients and 22 ± 3 kg / m2 in control
group. The levels obtained from the control group and individuals
with PCOS were compared with each other to reveal statistical
findings. After the approval of the Ethics Committee of the Istanbul
University Cerrahpaşa Medical Faculty, the samples were taken after
the approval of 3711. After sufficient samples were collected, IL-18
and MCP-1 analyzes were performed according to the information in
the ELISA kit prospectus. The level of the control group obtained
from the ELISA tests and the levels obtained from individuals with
PCOS were compared with each other and the statistical package for
the Social Sciences (SPSS) Mann-Whitney U test was used to
determine whether there was a statistically significant difference
between them. The p value to be calculated b0.05 was considered to
be significant. All values are listed as mean ± standard deviation.
Correlation regression tests were applied to determine whether
groups changed together.
Results
No significant difference was observed between PCOS and control
groups in age, BMI, IL-18, MCP-1 (p N .05). There was a significant
positive correlation between MCP-1 and BMI (r = 0.496 pδ0,01) in
the control group.
Conclusions
It is a proinflammatory cytokine in IL-18 and it is an inflamma-
tory process in PCOS and it is stated that IL-18 level is higher than
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the control group. This result confirms that IL-18 is also secreted
from adipose tissue, but it does not show release due to PCOS alone.
In our study, there was no difference in IL-18 levels between the
control and PCOS patients. There was a significant positive relation-
ship between MCP-1 and BMI (r= 0.496 pδ0,01) in the control
group. Based on this result, we can say that the increase in BMI in
healthy individuals triggered angiogenesis with the increase of MCP-
1, an important cytokine. Since there are studies on elevation of
MCP-1 with the increase of adipose tissue, it can be thought that the
increase in BMI with MCP-1 is related to PCOS-independent adipose
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Background-aim
The production of inflammatory cytokines and reactive oxygen
species are increased after Traumatic brain injury (TBI), and directly
related with worse outcome. The aim of the present study is the
evaluation of the effect of MLT over peripheral blood mononuclear
cells (PBMC) from TBI patients, focusing in the production of IL8, an
important pro inflamatory cytokine, and in the total antioxidant
capacity (TAC).
Methods
severe TBI (GCS 3–8) patients admitted to the Neurocritical Care
Unit were included. Blood samples were drawn within the first 48 h
after the injury (sample A) and at 48-96 h (sample B). For the
isolation of PBMC, CPT tubes containing ficoll gradient, were used.
Cells were spread 1x106cells/mL. Cell cultures were stimulated with
a mitogenic agent, PHA (8 μg/mL) in the presence or absence of MLT
(10–4 M), kept in humid atmosphere, 5% CO2 and 37 °C for 48 h,
after which supernatant were collected for subsequent quantification
of IL8 and TAC (quantified as “μM copper reducing equivalents”)
(CRE).
Results
We included 26 TBI patients and 7 healthy controls. Patients
showed higher IL8 levels compared to healthy group both in sample
A (p = .03) and sample B (p= .001). The administration of MLT
decreased IL8 production, hence reduced inflammation, reaching
statistical significance patient's sample B (p= .002) and control
sample (p = .028).
- TBI sample A:
o No MLT: 209590.55 pg/mL (IQR 157054.84–307,032.35).
o With MLT: 203677.73 pg/mL (IQR 159642.85–273,655.60).
- TBI sample B:
o No MLT: 193599.73 pg/mL(IQR 162684.07–257,997.52).
o With MLT: 164049.30 pg/mL (IQR 113577.48–242,150.55).
- Healthy controls:
o No MLT: 101059.53 pg/mL (IQR 82191.46–117,624.38).
o With MLT: 66636.95 pg/mL (IQR 59539.88–83,314.68).
Regarding TAC, we did not observe statistically significant
differences between patients and con-trols. Nevertheless, MLT
increased antioxidant capacity in all cultures performed:
- TBI sample A:
o No MLT: 184.91 CRE (IQR 146.39–233.45).
o With MLT: 269.86 CRE (IQR 235.22–367.29) (p b .001).
- TBI sample B:
o No MLT: 198.69 CRE (IQR 152.17–215.18).
o With MLT: 298.41 CRE (IQR 245.73–348.56) (p b .001).
- Healthy controls:
o No MLT: 177.06 CRE (IQR 131.26–191.70).
o With MLT: 284.21 (IQR 229.51–344.40) (p = .018).
Conclusions
These preliminary results confirm the antioxidant and anti-
inflammatory capacity of MLT in PBMC cultures of severe TBI
patients, highlighting MLT as a possible therapeutic strategy to
minimize morbidity and mortality in TBI patients.
doi:10.1016/j.cca.2019.03.934
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Background-aim
Pre-eclampsia and pregnancy hypertension are a major cause of
maternal mortality and morbidity, and are often the cause of
premature childbirth. Oxidative stress is considered to be one of
the factors inducing this pathology. The aim of this study was to
evaluate the biochemical parameters of oxidative stress in the first
trimester of pregnancy in patients with some risk of developing
preeclampsia.
Methods
The study involved two groups of pregnant women: the study
group (n= 90) with some risk condition of developing preeclamp-
sia, and the control group (n = 44) of healthy pregnant women
matched by ages. The study included pregnant women with
singleton pregnancy in the early first trimester between 11 and 14
weeks of pregnancy. We measured serum total oxidative status
(TOS), prooxidative-antioxidative balance (PAB) total antioxidative
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